Sugar, invert
Sugar, invert is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
115 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dysbiosis | D064806 | — | — | — | 1 | 4 | 5 | ||
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | 1 | — | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | 1 | — | 1 |
| Cerebral palsy | D002547 | G80 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | — | — | 2 | — | 4 | 6 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 12 | 13 |
| Critical illness | D016638 | — | 1 | — | — | 1 | 2 | ||
| Sepsis | D018805 | A41.9 | — | 1 | — | — | 1 | 2 | |
| Cross infection | D003428 | — | 1 | — | — | — | 1 | ||
| Nutrition disorders | D009748 | EFO_0001069 | — | 1 | — | — | — | 1 | |
| Immunotherapy | D007167 | 1 | 1 | — | — | — | 1 | ||
| Halitosis | D006209 | R19.6 | — | 1 | — | — | — | 1 | |
| Tongue diseases | D014060 | HP_0000171 | K14 | — | 1 | — | — | — | 1 |
| Precancerous conditions | D011230 | — | 1 | — | — | — | 1 | ||
| Colonic neoplasms | D003110 | C18 | — | 1 | — | — | — | 1 |
Show 2 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 2 | — | — | — | 7 | 9 | ||
| Inflammation | D007249 | 1 | — | — | — | 2 | 3 | ||
| Nutritional and metabolic diseases | D009750 | 1 | — | — | — | — | 1 | ||
| Endocrine bone diseases | D001849 | 1 | — | — | — | — | 1 | ||
| Human influenza | D007251 | EFO_0007328 | J11.1 | 1 | — | — | — | — | 1 |
| Typhoid fever | D014435 | EFO_0006789 | A01.0 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Overweight | D050177 | E66.3 | — | — | — | — | 5 | 5 | |
| Diet therapy | D004035 | — | — | — | — | 4 | 4 | ||
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 4 | 4 |
| Constipation | D003248 | HP_0002019 | K59.0 | — | — | — | — | 4 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 3 | 3 |
| Microbiota | D064307 | — | — | — | — | 3 | 3 | ||
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 3 | 3 |
| Healthy diet | D000072001 | — | — | — | — | 3 | 3 | ||
| Chronic renal insufficiency | D051436 | N18 | — | — | — | — | 3 | 3 | |
| Appetite regulation | D001069 | — | — | — | — | 2 | 2 |
Show 41 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | SUGAR, INVERT |
| INN | — |
| Description | Inverted sugar syrup, also called invert syrup, invert sugar, simple syrup, sugar syrup, sugar water, bar syrup, syrup USP, or sucrose inversion, is a syrup mixture of the monosaccharides glucose and fructose, that is made by hydrolytic saccharification of the disaccharide sucrose. This mixture's optical rotation is opposite to that of the original sugar, which is why it is called an invert sugar.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201647 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 0 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
72 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more